Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-013453)

Filing Details

Accession Number:: 0001209191-13-013453
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-04 17:30:33
Reporting Period:: 2013-02-28

Filing Date:: 2013-03-04
Accepted Time:: 2013-03-04 17:30:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1292519	Invivo Therapeutics Holdings Corp.	NVIV	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503383	Francis Reynolds	C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139	Ceo, Cfo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-02-28	2,250	$2.01	13,565,560	No	4	S	Direct
Common Stock	Disposition	2013-02-28	1,000	$2.02	13,564,560	No	4	S	Direct
Common Stock	Disposition	2013-02-28	1,000	$2.03	13,563,560	No	4	S	Direct
Common Stock	Disposition	2013-03-01	1,000	$2.07	13,562,560	No	4	S	Direct
Common Stock	Disposition	2013-03-01	1,000	$2.08	13,561,560	No	4	S	Direct
Common Stock	Disposition	2013-03-01	2,250	$2.13	13,559,310	No	4	S	Direct
Common Stock	Disposition	2013-03-04	4,250	$2.18	13,555,060	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,579	Indirect	By 401(k) Plan

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2012.